Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale
Authors
Keywords
-
Journal
IMMUNOLOGIC RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-16
DOI
10.1007/s12026-018-9032-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
- (2018) Jennifer C. Massey et al. Frontiers in Immunology
- Regulatory T cells in multiple sclerosis and myasthenia gravis
- (2017) K. M. Danikowski et al. Journal of Neuroinflammation
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis
- (2017) Maria Pia Sormani et al. NEUROLOGY
- Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
- (2017) Harold L. Atkins et al. Neurotherapeutics
- Cladribine to Treat Relapsing Forms of Multiple Sclerosis
- (2017) Gavin Giovannoni Neurotherapeutics
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Multiple sclerosis and related disorders: evolving pathophysiologic insights
- (2016) Amit Bar-Or LANCET NEUROLOGY
- Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
- (2015) Daniela Curro’ et al. Multiple Sclerosis Journal
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis
- (2015) Serena Ruggieri et al. JAMA Neurology
- Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study
- (2015) Daniela Curro’ et al. Multiple Sclerosis Journal
- T cell repertoire following autologous stem cell transplantation for multiple sclerosis
- (2014) Paolo A. Muraro et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
- (2014) O. Tuohy et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- (2014) Thomas P Leist et al. LANCET NEUROLOGY
- Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
- (2014) F. J. Quintana et al. NEUROLOGY
- Subcortical Deep Gray Matter Pathology in Patients with Multiple Sclerosis Is Associated with White Matter Lesion Burden and Atrophy but Not with Cortical Atrophy: A Diffusion Tensor MRI Study
- (2013) R. Cappellani et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Immunotherapy of Multiple Sclerosis
- (2013) Dimitrios Karussis BIODRUGS
- Cortical imaging in multiple sclerosis
- (2013) Marita Daams et al. CURRENT OPINION IN NEUROLOGY
- Hematopoietic stem cell transplantation in multiple sclerosis
- (2013) Dimitrios Karussis et al. Expert Review of Neurotherapeutics
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Meningeal and cortical grey matter pathology in multiple sclerosis
- (2012) Bogdan F Gh Popescu et al. BMC Neurology
- Clinical experience with stem cells and other cell therapies in neurological diseases
- (2012) Dimitrios Karussis et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Worldwide status of clinical experimentation with stem cells in neurologic diseases: Figure
- (2012) Dimitrios Karussis NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Cladribine
- (2011) Thomas P. Leist et al. CLINICAL NEUROPHARMACOLOGY
- Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting
- (2011) Dimitrios Karussis et al. Expert Review of Clinical Immunology
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
- (2011) GL Mancardi et al. Multiple Sclerosis Journal
- The predictive value of gray matter atrophy in clinically isolated syndromes
- (2011) M. Calabrese et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)
- (2010) D M. KARUSSIS et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens
- (2010) Koen Venken et al. JOURNAL OF NEUROIMMUNOLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis
- (2009) Mohit Neema et al. JOURNAL OF NEUROIMAGING
- Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
- (2009) Richard K Burt et al. LANCET NEUROLOGY
- Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis
- (2009) Antonia Ceccarelli et al. Multiple Sclerosis Journal
- B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data
- (2008) Kathleen Hawker CURRENT OPINION IN NEUROLOGY
- B lymphocytes - chief players and therapeutic targets in autoimmune diseases
- (2008) Moncef Zouali Frontiers in Bioscience-Landmark
- Th17 cells in human disease
- (2008) Laura A. Tesmer et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now